Adagio Medical (ADGM) Director Sandra Gardiner Receives Award

What Happened

• Sandra A. Gardiner, a director of Adagio Medical Holdings, Inc. (ADGM), was granted a derivative award of 30,000 shares (reported as an option grant) on 2026-06-16. The Form 4 records the acquisition as an award (code A) at $0.00 (no cash outlay reported). This is a compensation grant under the company's director plan rather than an open-market purchase or sale.

Key Details

• Transaction date and type: 2026-06-16 — Award/Grant of 30,000 derivative shares (Form 4 code A).
• Reported price: $0.00 (no cash paid reported at grant).
• Shares owned after transaction: Not disclosed in the filing.
• Vesting: Per the filing footnote, the option vests in equal monthly installments over one year (1/12th each month) beginning 06/16/2026.
• Plan/authority: Granted under the Issuer’s Non-Employee Director Compensation Policy and the 2024 Equity Incentive Plan.
• Timeliness: The Form 4 was filed on 2026-08-12 for a 2026-06-16 grant — the filing was delayed beyond the typical two-business-day reporting window.

Context

• This was an equity compensation grant for a non-employee director — a routine form of director pay. It is a derivative award (options) that vests over time; there is no indication the options were exercised or sold. Such awards are common and do not by themselves signal buying or selling intent in the open market, though they increase potential future share dilution if exercised.